Showing results (81-90 of 233) with videos related to

Sort By:
Pageof 24
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|December 4, 2025
A novel mineralocorticoid receptor blocker, CS-3150, improves insulin resistance and reduces inflammation in db/db miceOyunbileg Bavuu, Daiju Fukuda, Uugantsetseg Munkhjargal, et al.
Scientific Reports|August 3, 2019
Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic micePhuong Tran Pham, Daiju Fukuda, Shusuke Yagi, et al.
Frontiers in Endocrinology|March 3, 2020
Levels of Adiponectin Expression in Peri-Renal and Subcutaneous Adipose Tissue and Its Determinants in Human Biopsied SamplesGulinu Maimaituxun, Daiju Fukuda, Hirofumi Izaki, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|December 9, 2014
Histopathological heterogeneity of in-stent restenosis in four coronary endarterectomy specimensAkira Takashima, Michio Shimabukuro, Minoru Tabata, et al.
Journal of Atherosclerosis and Thrombosis|February 27, 2020
Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient MiceArief Rahadian, Daiju Fukuda, Hotimah Masdan Salim, et al.
International Journal of Cardiology|March 31, 2022
Epicardial adipose tissue volume is an independent predictor of left ventricular reverse remodeling in patients with non-ischemic cardiomyopathyYumi Yamaguchi, Atsushi Shibata, Toshitake Yoshida, et al.
Journal of the American College of Cardiology|May 17, 2005
Multiple plaque rupture and C-reactive protein in acute myocardial infarctionAtsushi Tanaka, Kenei Shimada, Toshihiko Sano, et al.
European Journal of Pharmacology|December 23, 2017
Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injuryTomoya Hara, Daiju Fukuda, Kimie Tanaka, et al.
Pageof 24